Cargando…

Targeting CXCL12/CXCR4 Signaling with AMD3100 Might Selectively Suppress CXCR4+ T-Cell Chemotaxis Leading to the Alleviation of Chronic Prostatitis

BACKGROUND: Chronic nonbacterial prostatitis (CNP) has a high incidence, low cure rate, and unclear pathogenesis. Here, we aimed to systematically identify effective diagnostic and therapeutic targets for CNP. METHODS: Prostate tissues were obtained from established mouse models and negative control...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Meng, Liu, Yi, Chen, Jing, Chen, Lei, Zhang, Li, Chen, Xianguo, Hao, Zongyao, Liang, Chaozhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037856/
https://www.ncbi.nlm.nih.gov/pubmed/35479835
http://dx.doi.org/10.2147/JIR.S352336
_version_ 1784693807562883072
author Zhang, Meng
Liu, Yi
Chen, Jing
Chen, Lei
Zhang, Li
Chen, Xianguo
Hao, Zongyao
Liang, Chaozhao
author_facet Zhang, Meng
Liu, Yi
Chen, Jing
Chen, Lei
Zhang, Li
Chen, Xianguo
Hao, Zongyao
Liang, Chaozhao
author_sort Zhang, Meng
collection PubMed
description BACKGROUND: Chronic nonbacterial prostatitis (CNP) has a high incidence, low cure rate, and unclear pathogenesis. Here, we aimed to systematically identify effective diagnostic and therapeutic targets for CNP. METHODS: Prostate tissues were obtained from established mouse models and negative controls and were used for mRNA array sequencing and immunohistochemistry (IHC) staining. Predominant pathways were identified based on pathway enrichment analysis and pharmaceutical experiments. We also investigated the functional role of CXCL12 on CP, a critical factor belonging to the predominant chemotaxis pathway, and employed IHC staining to explore the influence of the CXCL12/CXCR4 axis on the activation of the NF-κB, AKT, and STAT3 signaling pathways. Serum samples derived from both CNP cases and healthy controls were used to determine the secretion level of CXCL12. RESULTS: By employing mRNA array sequencing and immunohistochemistry, we found that CXCR4, CXCL12, CD44, and OFLM4 were highly expressed in the infiltrated inflammatory T cells of the prostate tissues generated from CNP mice, while they were rarely expressed on the epithelial cells. Based on the pathway enrichment results, we applied pathway inhibitors to suppress the activity of these classic pathways. We found that targeting the CXCL12/CXCR4 axis with its specific antagonist AMD3100 remarkably alleviated inflammatory infiltration of the prostate in CNP models. Similar results were obtained when we replaced AMD3100 with adenovirus-associated virus (AAV)-shCxcl12. To clarify the potential mechanisms of how the CXCL12/CXCR4 axis influences the pathogenesis of CNP, we tested the classical downstream pathways. The results suggested that p-Akt, p-STAT3, and p-NF-κB were more highly expressed on the inflammatory cells of the prostate derived from the CNP model and were partly suppressed after applying AMD3100 or delivering AAV-shCxcl12, indicating that the CXCL12/CXCR4 axis potentially functioned through AKT/NF-κB and STAT3 signaling to influence the pathogenesis of CNP. CONCLUSION: Our study provides potential diagnostic biomarkers and therapeutic targets for CNP.
format Online
Article
Text
id pubmed-9037856
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-90378562022-04-26 Targeting CXCL12/CXCR4 Signaling with AMD3100 Might Selectively Suppress CXCR4+ T-Cell Chemotaxis Leading to the Alleviation of Chronic Prostatitis Zhang, Meng Liu, Yi Chen, Jing Chen, Lei Zhang, Li Chen, Xianguo Hao, Zongyao Liang, Chaozhao J Inflamm Res Original Research BACKGROUND: Chronic nonbacterial prostatitis (CNP) has a high incidence, low cure rate, and unclear pathogenesis. Here, we aimed to systematically identify effective diagnostic and therapeutic targets for CNP. METHODS: Prostate tissues were obtained from established mouse models and negative controls and were used for mRNA array sequencing and immunohistochemistry (IHC) staining. Predominant pathways were identified based on pathway enrichment analysis and pharmaceutical experiments. We also investigated the functional role of CXCL12 on CP, a critical factor belonging to the predominant chemotaxis pathway, and employed IHC staining to explore the influence of the CXCL12/CXCR4 axis on the activation of the NF-κB, AKT, and STAT3 signaling pathways. Serum samples derived from both CNP cases and healthy controls were used to determine the secretion level of CXCL12. RESULTS: By employing mRNA array sequencing and immunohistochemistry, we found that CXCR4, CXCL12, CD44, and OFLM4 were highly expressed in the infiltrated inflammatory T cells of the prostate tissues generated from CNP mice, while they were rarely expressed on the epithelial cells. Based on the pathway enrichment results, we applied pathway inhibitors to suppress the activity of these classic pathways. We found that targeting the CXCL12/CXCR4 axis with its specific antagonist AMD3100 remarkably alleviated inflammatory infiltration of the prostate in CNP models. Similar results were obtained when we replaced AMD3100 with adenovirus-associated virus (AAV)-shCxcl12. To clarify the potential mechanisms of how the CXCL12/CXCR4 axis influences the pathogenesis of CNP, we tested the classical downstream pathways. The results suggested that p-Akt, p-STAT3, and p-NF-κB were more highly expressed on the inflammatory cells of the prostate derived from the CNP model and were partly suppressed after applying AMD3100 or delivering AAV-shCxcl12, indicating that the CXCL12/CXCR4 axis potentially functioned through AKT/NF-κB and STAT3 signaling to influence the pathogenesis of CNP. CONCLUSION: Our study provides potential diagnostic biomarkers and therapeutic targets for CNP. Dove 2022-04-21 /pmc/articles/PMC9037856/ /pubmed/35479835 http://dx.doi.org/10.2147/JIR.S352336 Text en © 2022 Zhang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Zhang, Meng
Liu, Yi
Chen, Jing
Chen, Lei
Zhang, Li
Chen, Xianguo
Hao, Zongyao
Liang, Chaozhao
Targeting CXCL12/CXCR4 Signaling with AMD3100 Might Selectively Suppress CXCR4+ T-Cell Chemotaxis Leading to the Alleviation of Chronic Prostatitis
title Targeting CXCL12/CXCR4 Signaling with AMD3100 Might Selectively Suppress CXCR4+ T-Cell Chemotaxis Leading to the Alleviation of Chronic Prostatitis
title_full Targeting CXCL12/CXCR4 Signaling with AMD3100 Might Selectively Suppress CXCR4+ T-Cell Chemotaxis Leading to the Alleviation of Chronic Prostatitis
title_fullStr Targeting CXCL12/CXCR4 Signaling with AMD3100 Might Selectively Suppress CXCR4+ T-Cell Chemotaxis Leading to the Alleviation of Chronic Prostatitis
title_full_unstemmed Targeting CXCL12/CXCR4 Signaling with AMD3100 Might Selectively Suppress CXCR4+ T-Cell Chemotaxis Leading to the Alleviation of Chronic Prostatitis
title_short Targeting CXCL12/CXCR4 Signaling with AMD3100 Might Selectively Suppress CXCR4+ T-Cell Chemotaxis Leading to the Alleviation of Chronic Prostatitis
title_sort targeting cxcl12/cxcr4 signaling with amd3100 might selectively suppress cxcr4+ t-cell chemotaxis leading to the alleviation of chronic prostatitis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037856/
https://www.ncbi.nlm.nih.gov/pubmed/35479835
http://dx.doi.org/10.2147/JIR.S352336
work_keys_str_mv AT zhangmeng targetingcxcl12cxcr4signalingwithamd3100mightselectivelysuppresscxcr4tcellchemotaxisleadingtothealleviationofchronicprostatitis
AT liuyi targetingcxcl12cxcr4signalingwithamd3100mightselectivelysuppresscxcr4tcellchemotaxisleadingtothealleviationofchronicprostatitis
AT chenjing targetingcxcl12cxcr4signalingwithamd3100mightselectivelysuppresscxcr4tcellchemotaxisleadingtothealleviationofchronicprostatitis
AT chenlei targetingcxcl12cxcr4signalingwithamd3100mightselectivelysuppresscxcr4tcellchemotaxisleadingtothealleviationofchronicprostatitis
AT zhangli targetingcxcl12cxcr4signalingwithamd3100mightselectivelysuppresscxcr4tcellchemotaxisleadingtothealleviationofchronicprostatitis
AT chenxianguo targetingcxcl12cxcr4signalingwithamd3100mightselectivelysuppresscxcr4tcellchemotaxisleadingtothealleviationofchronicprostatitis
AT haozongyao targetingcxcl12cxcr4signalingwithamd3100mightselectivelysuppresscxcr4tcellchemotaxisleadingtothealleviationofchronicprostatitis
AT liangchaozhao targetingcxcl12cxcr4signalingwithamd3100mightselectivelysuppresscxcr4tcellchemotaxisleadingtothealleviationofchronicprostatitis